The unknown risk of chemotherapy for patients with cancer

Patients with cancer are little or no informed about the relationship of their disease to venous thrombosis and its consequences, although cancer-associated thrombosis is the second leading cause of death in this class of patients and is associated with early mortality in the stage of chemotherapy.

The problem focuses on patients’ lack of information from their medical team about the risk of thrombosis during cancer treatment. Indeed, the need for information is also confirmed by the findings of the European Cancer Patient Coalition (ECPC) survey, according to which only 8% of patients received information from their doctor on the risk of cancer-related thrombosis, and even verbally.